Skip to Content

What is the difference between Lumify and Alphagan P?

Answers (1)

Official Answer by Drugs.com 7 Mar 2018

In December 2017, the FDA approved Bausch + Lomb’s Lumify (brimonidine tartrate ophthalmic solution 0.025%) as the first over-the-counter (OTC) eye drop that contains low-dose brimonidine tartrate for the treatment of ocular redness (red eyes). Brimonidine (Alphagan P) was first approved by the FDA for intraocular pressure (IOP) reduction in glaucoma patients and is available at higher doses in prescription eye care products.

Lumify, an alpha-adrenergic agonist eye drop, selectively constricts veins in the eye, increasing the availability of oxygen and reducing the potential risk of rebound redness (red eyes).

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of cancer is Daurismo (glasdegib) used to treat?

Updated 3 days ago 1 answerFAQ by Drugs.com

What type of drug is Vitrakvi (larotrectinib)?

Updated 3 days ago 1 answerFAQ by Drugs.com

What is the difference between Truxima and Rituxan?

Updated 3 days ago 1 answerFAQ by Drugs.com

What type of leukemia is Xospata (gilteritinib) used to treat?

Updated 3 days ago 1 answerFAQ by Drugs.com

What is the difference between Tolsura and Sporanox?

Updated 2 days ago 1 answerFAQ by Drugs.com